Attached files
file | filename |
---|---|
S-1/A - S-1/A - Voyager Therapeutics, Inc. | a2226469zs-1a.htm |
EX-10.3 - EX-10.3 - Voyager Therapeutics, Inc. | a2226469zex-10_3.htm |
EX-10.4 - EX-10.4 - Voyager Therapeutics, Inc. | a2226469zex-10_4.htm |
EX-10.11 - EX-10.11 - Voyager Therapeutics, Inc. | a2226469zex-10_11.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated June 19, 2015, except for Note 15(b) as to which the date is October 30, 2015, in the Registration Statement (Form S-1 No. 333-207367) and related Prospectus of Voyager Therapeutics, Inc. dated November 4, 2015.
/s/ Ernst & Young, LLP
Boston,
Massachusetts
November 4, 2015
Consent of Independent Registered Public Accounting Firm